Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleanor Barnes

Showing results (151-160 of 222) with videos related to

Pageof 23
Sort By:
Hepatology Communications|April 26, 2024
Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: Open-label, multicenter, single-arm, phase II trialGideon M Hirschfield, Katherine Arndtz, Amanda Kirkham, et al.
Alimentary Pharmacology & Therapeutics|April 17, 2020
Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolomeAhmad Moolla, Jasper de Boer, David Pavlov, et al.
Hepatology (Baltimore, Md.)|December 25, 2009
Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitopeChristoph Neumann-Haefelin, Jörg Timm, Julia Schmidt, et al.
Frontiers in Immunology|February 5, 2019
A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV CoinfectionFelicity Hartnell, Anthony Brown, Stefania Capone, et al.
BMJ Open|January 20, 2025
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trialMelanie Varley, Joanne Euden, Richard Adams, et al.
Plos One|June 14, 2013
A modified RNA-Seq approach for whole genome sequencing of RNA viruses from faecal and blood samplesElizabeth M Batty, T H Nicholas Wong, Amy Trebes, et al.
Nature Genetics|April 11, 2017
Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virusM Azim Ansari, Vincent Pedergnana, Camilla L C Ip, et al.
BMJ Health & Care Informatics|November 20, 2020
National Institute for Health Research Health Informatics Collaborative: development of a pipeline to collate electronic clinical data for viral hepatitis researchDavid Anthony Smith, Tingyan Wang, Oliver Freeman, et al.
Hepatology (Baltimore, Md.)|December 31, 2013
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitisKirsten Boonstra, Emma L Culver, Lucas Maillette de Buy Wenniger, et al.
Science Translational Medicine|November 8, 2014
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memoryLeo Swadling, Stefania Capone, Richard D Antrobus, et al.
Pageof 23

Showing results (151-160 of 222) with videos related to

Sort By:
Pageof 23
Hepatology Communications|April 26, 2024
Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: Open-label, multicenter, single-arm, phase II trialGideon M Hirschfield, Katherine Arndtz, Amanda Kirkham, et al.
Alimentary Pharmacology & Therapeutics|April 17, 2020
Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolomeAhmad Moolla, Jasper de Boer, David Pavlov, et al.
Hepatology (Baltimore, Md.)|December 25, 2009
Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitopeChristoph Neumann-Haefelin, Jörg Timm, Julia Schmidt, et al.
Frontiers in Immunology|February 5, 2019
A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV CoinfectionFelicity Hartnell, Anthony Brown, Stefania Capone, et al.
BMJ Open|January 20, 2025
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trialMelanie Varley, Joanne Euden, Richard Adams, et al.
Plos One|June 14, 2013
A modified RNA-Seq approach for whole genome sequencing of RNA viruses from faecal and blood samplesElizabeth M Batty, T H Nicholas Wong, Amy Trebes, et al.
Nature Genetics|April 11, 2017
Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virusM Azim Ansari, Vincent Pedergnana, Camilla L C Ip, et al.
BMJ Health & Care Informatics|November 20, 2020
National Institute for Health Research Health Informatics Collaborative: development of a pipeline to collate electronic clinical data for viral hepatitis researchDavid Anthony Smith, Tingyan Wang, Oliver Freeman, et al.
Hepatology (Baltimore, Md.)|December 31, 2013
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitisKirsten Boonstra, Emma L Culver, Lucas Maillette de Buy Wenniger, et al.
Science Translational Medicine|November 8, 2014
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memoryLeo Swadling, Stefania Capone, Richard D Antrobus, et al.
Pageof 23